Published November 2, 2017
| Version v1
Patent
Open
METHODS AND COMPOSITIONS PERTAINING TO HUMAN CEREBRAL CAVERNOUS MALFORMATIONS
Contributors
Patent applicant:
Description
The disclosure is based on the discovery that aberrant immune responses are contributing to the pathogenicity of CCMs in patients, and that blocking those responses treats the CCM. Described herein is a method for treating CCMs in a patient in need thereof comprising administering a therapeutically effective amount of a B-cell immunomodulation therapy to the patient.
Files
US20170313779.pdf
Files
(2.5 MB)
| Name | Size | Download all |
|---|---|---|
|
md5:9f803f235720c86968194dbab6a42a20
|
2.5 MB | Preview Download |
Additional details
Identifiers
- Patent application number
- US 201515523521 A
- Patent number
- US 2017/0313779 A1
- Other
- oai:uchicago.tind.io:8485
Dates
- Patent filed
-
2015-11-05